UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K/A
(Amendment
No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 13, 2007
GENOMIC HEALTH, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-51541
|
|
77-0552594 |
(State or Other Jurisdiction of
|
|
(Commission File Number)
|
|
(I.R.S. Employer |
Incorporation)
|
|
|
|
Identification No.) |
|
|
|
301 Penobscot Drive
Redwood City, California
(Address of principal executive offices)
|
|
94063
(Zip Code) |
(650) 556-9300
(Registrants telephone number,
including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligations of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240-13e-4(c))
Genomic
Health, Inc. (the Company) is filing this Amendment No. 1 to its Current Report on Form 8-K
filed with the Securities and Exchange Commission on February 6,
2007 (the Form 8-K) to update the information set forth in Item 8.01 of the Form 8-K by amending
and restating the disclosure set forth therein.
Item 8.01 Other Events.
The Company has changed the date of the 2007 Annual Meeting of Stockholders from May 17, 2007 to
June 12, 2007, at such place and time as will be set forth in the Companys proxy statement
relating to that meeting.
A stockholder proposal not included in the proxy statement for the Companys 2007 Annual Meeting of
Stockholders will be ineligible for presentation at the meeting unless the stockholder gives timely
notice of the proposal in writing to the Secretary of the Company at the principal executive
offices of the Company and otherwise complies with the provisions of the Companys Bylaws. For the
2007 Annual Meeting of Stockholders, to be timely, the Companys Bylaws provide that the Secretary
of the Company must have received the stockholders notice not earlier than ninety (90) days nor
more than one hundred twenty (120) days in advance of the date the Companys proxy statement was
released to the stockholders in connection with the previous years annual meeting of stockholders.
For the Companys 2007 Annual Meeting of Stockholders, stockholders must have submitted written
notice to the Secretary in accordance with the foregoing Bylaw provisions not earlier than December
29, 2006 nor later than January 28, 2007.
2